Media free from serum, proteins and other molecules for support of various primary immune cells.
Various human - and animal primary cells to progress your immunotherapy research. Healthy state and disease state primary cells.
Antibodies that are suitable for identification & validation of immuno-oncology key targets.
Various assays that enable immuno-oncology screening of kinase activity and - inhibition, cell viability, metabolism, oxidative stress and many more.